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Central diabetes insipidus is an uncommon feature of malaria. A previously healthy 72-year-old man presented with fever, rigors,
and altered mental status after a recent trip to Liberia, a country known for endemic falciparum malaria. Investigations confirmed
plasmodium falciparum parasitemia. Within one week after admission, the serum sodium rose to 166mEq/L and the urine
output increased to 7 liters/day. Other labs were notable for a high serum osmolality, low urine osmolality, and low urine specific
gravity.The hypernatremia did not respond to hypotonic fluids. Diabetes insipidus was suspected and parenteral desmopressin was
started with a prompt decrease in urinary output and improvement in mental status. Additional testing showed normal anterior
pituitary hormones.The desmopressin was eventually tapered off with complete resolution of symptoms. Central diabetes insipidus
occurred likely as a result of obstruction of the neurohypophyseal microvasculature. Other endocrinopathies that have been
reported with malaria include hyponatremia, adrenal insufficiency, hypothyroidism, hypocalcemia, hypophosphatemia, hyper-,
and hypoglycemia, but none manifested in our patient.Though diabetes insipidus is a rare complication of malaria, clinicians need
to be aware of this manifestation, as failure to do so may lead to fatality particularly if the patient is dehydrated.
1. Introduction
Malaria remains a major public health challenge. As per
WHO, there were about 198 million cases of malaria in 2013
with an estimated 584,000 deaths. Cerebralmalaria is defined
as an unexplained coma in a patient with malarial para-
sitemia. This is a life-threatening complication of malaria.
Cytoadherence and sequestration of red blood cells in the
microvasculature are thought to be the key pathophysiology.
Here we present the case report of a 72-year-old patient who
developed an unusual complication of cerebral malaria and
central diabetes insipidus followed by a review on endocrine
complications associated with malaria.
2. Case Presentation
A previously healthy 72-year-old man presented with a four-
day history of fever, rigors, back pain, and altered mental
status. He had returned from a trip to Liberia, a country
with endemic chloroquine-resistant falciparum malaria, two
weeks prior to presentation. He took doxycycline chemopro-
phylaxis during the trip however discontinued it prematurely
upon return.
Investigations confirmed plasmodium falciparum para-
sitemia (greater than 10%) with acute kidney injury. He was
started on parenteral quinidine followed by artesunate and
exchange transfusion. The serum sodium was 132mEq/L at
admission. A head CT scan at admission did not reveal any
acute findings. A brain MRI done 2 months prior as work up
of an unexplained syncope was within normal limits.
Within a week after admission, there was rise in serum
sodium and urine output as shown in Figure 1. Other studies
were notable for high serum osmolality (354mOsm/Kg), low
urine osmolality (199Osm/kg), and low urine specific gravity
(1.010).
The hypernatremia did not respond to fluid therapy.
Diabetes insipidus was suspected based on the above findings
and parenteral desmopressin was started with a prompt
decrease in serum sodium and urine output (Figure 1).
This was accompanied by a significant improvement in
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Figure 1: Graph of patient’s serum sodium and urine output in
response to desmopressin over hospital course. Sub-Q: subcuta-
neous; DDAVP: desmopressin; PO: per os; BID: twice daily.
mental status. Additional testing revealed morning cortisol
15.5mcg/dL, free T4 1.3 ng/dL, and prolactin 34 ng/mL.These
were done to exclude possibilities of adrenal and thyroid
insufficiency. Acute kidney injury resolved with hydration
and other electrolytes were found to be within normal limits
as follows: calcium: 8.8mg/dL, phosphorous: 3.2mg/dL, and
magnesium: 2.1mg/dL. Fasting glucose ranged between 70
and 130mg/dL during the hospital stay. Desmopressin was
eventually changed to 0.05mg twice daily orally on discharge
and 0.05mg at bedtime a week later. The serum sodium
was 134mEq/L on the day of discharge. Desmopressin was
discontinued two weeks later with complete resolution of
thirst and polyuria and serum sodium remained normal at
138mEq/L during that time.
3. Discussion
We have described a patient who presented with cerebral
malaria developing a very rare complication, central dia-
betes insipidus. The classic presentation of malaria with
relapsing and remitting fevers occurs in only 50–70% of
persons infected with plasmodium species [1] and the rest is
accounted by atypical features.
3.1. Literature Review on Endocrine Abnormalities Associated
with Malaria. Endocrine and metabolic abnormalities that
have been reported in the literature with malaria include
hyponatremia, diabetes insipidus, hypercortisolemia, adrenal
insufficiency, primary and secondary hypothyroidism, hyper-
and hypoglycemia, hyper- and hypokalemia, hypophos-
phatemia, hypocalcemia, and hypomagnesemia. Hypona-
tremia could result due to SIADH(syndromeof inappropriate
antidiuretic hormone), cerebral salt wasting, or gastrointesti-
nal and renal losses. Holst and his group [2] estimated antidi-
uretic hormone (ADH) concentrations along with serum and
urine osmolality, serum, and urine sodium in 17 patients with
falciparum malaria and found that the ADH concentrations
were raised inappropriately in relation to the serum osmolal-
ity in 6 patients.The highADHmight be amarker of decrease
in the effective plasma volume suggestingTNF-alpha induced
endothelial damage and leakage. However, dehydrationmore
than SIADH was suggested as the cause of hyponatremia in
severe childhoodmalaria according to English and colleagues
[3]. In their study 47 children with cerebral malaria were
prospectively recruited and serial indices of fluid/electrolyte
balance and renal function were monitored during admis-
sion. 21% of patients had pronounced hyponatremia and in
comparison to the eunatremic group, hyponatremic children
gained less weight, had higher urea concentrations, and were
more acidotic consistent with dehydration.
Diabetes insipidus as occurred in our patient could have
resulted due to obstruction of neurohypophyseal microvas-
culature by the malarial parasites. Mature forms of the para-
site, including trophozoites and the meronts, sequester in the
microvasculature; nonparasitized RBCs adhere to the para-
sitized RBCs (rosetting) and parasitized RBCs adhere among
each other (agglutination). As the parasites grow within
the RBCs, they become less deformable causing mechani-
cal obstruction and impaired microvascular circulation. A
variety of proinflammatory cytokines, including TNF-alpha
increases the cytoadherence [4]. Only a few case reports have
described diabetes insipidus as a complication of cerebral
malaria. In a study conducted by Grimwade et al. [5], in 411
patients with malaria, 37 of 175 patients with severe malaria
had polyuria, and 10 patients had low urine osmolality and
high serum osmolality consistent with diabetes insipidus.
Another case report by Schubert et al. [6] described central
diabetes insipidus in a patient with cerebral malaria, which
responded to desmopressin. The microvascular obstruction
gradually resolves with treatment of the parasitemia and
hence the requirement of desmopressin is temporary as illus-
trated in our case. The mild hyperprolactinemia noted was
likely secondary to the temporary cessation of the regulatory
dopamine impulses reaching the anterior pituitary.
Both cortisol excess and adrenal insufficiencies have been
reported as a complication of malaria. In a study conducted
by Wilson et al. [7] it was shown that, in persons infected
with malaria, there is inappropriate suppression of cortisol
after one milligram dexamethasone suppression test. They
proposed that this could be possibly due to proinflammatory
cytokines activating the adrenal cortex in order to protect
from complications such as hypoglycemia associated with
the infection. On the other hand, Davis et al. [8] in a study
of 9 patients with complicated malaria found that the rise
in ACTH and cortisol after CRH stimulation was blunted.
The primary and secondary adrenal insufficiency may be
attenuated by increased circulating IL-6 and impaired cortisol
metabolism. Authors also suggested that if hypoglycemia
was present and/or if cortisol levels were within or below
the normal range, stress dose steroids should be considered.
Secondary adrenal insufficiency and central hypothyroidism
leading to delayed anesthetic recovery have been reported in
a patient with history of cerebral malaria [9]. Another inter-
esting feature described in the literature includes cortisolemia
leading to loss of immunity in pregnant women infected with
falciparum malaria. In this study Adam et al. investigated 50
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consecutive women with uncomplicated falciparum malaria
and observed a positive correlation between cortisol levels
and parasite count (𝑟 = 0.332, 𝑃 = 0.02) [10]. In our patient,
there was no evidence of either primary or secondary adrenal
insufficiency depicted by normal fasting morning cortisol
of 15.5mcg/dL and normal blood pressure throughout his
hospital stay.
Thyroid abnormalities previously published include pri-
mary and secondary hypothyroidism [11].These changesmay
be an adaptation to the accelerated catabolism when infected
withmalaria; however, the role of thyroid replacement in such
patients is uncertain. Wartofsky et al. [12] studied thyroid
function in healthy volunteers who were inoculated with
malaria; they found an initial decrease followed by a rebound
rise in thyroid hormone release. Our patient had normal
thyroid axis as illustrated by normal free T4 of 1.3 ng/dL.
Thien and coworkers studied gluconeogenesis in different
populations of individuals affected with falciparum malaria
to various degrees of severity and found an increased rate
of gluconeogenesis in both complicated and uncomplicated
cases.This findingwas additionally supported by the presence
of low levels of the gluconeogenic amino acid precursor,
glutamine. The authors commented that prolonged fast-
ing is an important risk factor for hypoglycemia and full
recognition of this complication is especially critical in the
most susceptible population, children and pregnant women
[13]. Another study by Kawo and colleagues did not find
any significant difference in the frequency of hypoglycemia
between malarial and control patients (5.2% versus 11.2%)
nor between the comatose (11.1% versus 18.8%) and conscious
malarial and control (1.6% versus 7.0%) subgroups [14].
Similar to the Thien et al. study, the authors emphasized
hypoglycemia as a consequence of prolonged fasting resulting
from glycogen depletion. Hyperglycemia could also occur
because of associated sepsis or due to the stress response with
increased counterregulatory hormones [15, 16]. Our patient
was, however, euglycemic throughout the course of hospital
stay.
Hyperkalemia associated with severe malaria is thought
to be due to a combination of acute renal failure and lactic
acidosis. Increased extra cellular release of potassium could
also occur in the context of hemolysis and rhabdomyolysis.
Our patient, although presented with acute kidney injury, did
not develop hyperkalemia and there was a prompt decrease in
creatinine with hydration. Hypokalemia had been described
in up to 40% of children [17] with severe malaria byMaitland
et al. within a few hours of hospitalization. The authors sug-
gested that it could be due to rapid correction of acidosis lead-
ing to intracellular shift of potassium and/because of renal
potassium loss. A lower renal threshold for phosphorus could
lead to hypophosphatemia. Screening for hypophosphatemia
was especially important in our patient as low phosphorous
can further worsen the neuro hypophyseal perfusion through
platelet dysfunction and decreased 2,3-diphosphoglycerate.
The main reason for hypocalcemia cited in the literature is
a blunted response of parathyroid hormone to hypocalcemia,
also called “sick euparathyroid state” [18].Mild asymptomatic
hypomagnesemia is also known to occur with malaria and
this in turn alters the set point of parathyroid hormone
release with hypocalcemia. Throughout the hospital stay, our
patient had normal potassium, phosphorous calcium, and
magnesium levels.
In summary, central diabetes insipidus is a rare and
atypical complication of malaria. Although uncommon, clin-
icians need to be aware of this manifestation since early
diagnosis prevents serious outcomes. Particularly in hot,
humid, and arid climates of sub-Saharan Africa and Indian
subcontinent where parasitic infection and dehydration are
common, dehydration compounded by diabetes insipidus
can even lead to death if left unrecognized. Our patient did
not have other metabolic or hormonal abnormalities that
have been reported in the literature including hyponatremia,
adrenal insufficiency, cortisol excess, thyroid dysfunction,
hyper/hypoglycemia, or other electrolyte imbalances.
In our patient the diabetes insipidus symptoms lasted
for around four weeks and desmopressin was eventually
tapered off. It is important to carefully monitor other anterior
pituitary hormone status along with electrolytes while caring
for a patient with acute onset of central diabetes insipidus.
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